跳转至内容
Merck

75061

Sigma-Aldrich

三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸

≥95.0% (CHN)

别名:

1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三叔丁酯

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C28H52N4O8
分子量:
572.73
MDL號碼:
分類程式碼代碼:
12352108
PubChem物質ID:
NACRES:
NA.22

品質等級

化驗

≥95.0% (CHN)

形狀

lumps

官能基

carboxylic acid
ester

SMILES 字串

CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(O)=O

InChI

1S/C28H52N4O8/c1-26(2,3)38-23(35)19-30-12-10-29(18-22(33)34)11-13-31(20-24(36)39-27(4,5)6)15-17-32(16-14-30)21-25(37)40-28(7,8)9/h10-21H2,1-9H3,(H,33,34)

InChI 密鑰

RVUXZXMKYMSWOM-UHFFFAOYSA-N

相关类别

應用

1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三丁酯(tri BOC-DOTA)可作为反应物来制备:
  • 以DOTA-LAE(乳糖酸-乙二胺)功能化修饰的钆离子,其可用作磁共振成像(MRI)的造影剂。
  • 熊果酸的DOTA偶联物和ZD264Cu-DOTA偶联物

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
Jeong Y and Na K
Biomaterials research, 22(1), 17-17 (2018)
Preparation and evaluation of ZD2 peptide 64Cu-DOTA conjugate as a positron emission tomography probe for detection and characterization of prostate cancer
Han Z, et al.
ACS Omega, 4(1), 1185-1190 (2019)
Benjamin Poret et al.
Biomolecules, 10(3) (2020-03-25)
Overexpression of G protein-coupled receptors (GPCRs) in tumours is widely used to develop GPCR-targeting radioligands for solid tumour imaging in the context of diagnosis and even treatment. The human vasoactive neuropeptide urotensin II (hUII), which shares structural analogies with somatostatin
Synthesis and cytotoxicity evaluation of DOTA-conjugates of ursolic acid
Kahnt, M, et al.
Molecules (Basel), 24(12), 2254-2254 (2019)
Lubinda Mbundi et al.
Nanomaterials (Basel, Switzerland), 8(6) (2018-06-06)
The control of osteoblast/osteoclast cross-talk is crucial in the bone remodelling process and provides a target mechanism in the development of drugs for bone metabolic diseases. Osteoprotegerin is a key molecule in this biosignalling pathway as it inhibits osteoclastogenesis and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门